Dumont Global

Dumont Global is a private investment partnership co-founded in 2018 by Chris Yetter and the partners of 3G Capital. Our strategy focuses on orphaned assets, those that fall outside the scope of traditional asset managers, due to mandate or behavioral constraints. Some examples include micro-industries, esoteric geographies, and complex regulatory landscapes. The partnership manages one of the largest portfolios in the U.S. regulated cannabis industry, including assets in cultivation, processing, brands, and retail stores. Dumont also invests in research on novel therapeutics for mental health disorders such as psilocybin and 5-MeO-DMT. Dumont Global is headquartered in New York City, NY.